Chemoinformaics analysis of 11(13)-Dehydroivaxillin
Molecular Weight | 264.321 | nRot | 0 |
Heavy Atom Molecular Weight | 244.161 | nRig | 20 |
Exact Molecular Weight | 264.136 | nRing | 4 |
Solubility: LogS | -2.322 | nHRing | 3 |
Solubility: LogP | 1.375 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 3 |
No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 3 |
No. of Carbon atom | 15 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 41.5939 |
nHD | 0 | BPOL | 26.1401 |
QED | 0.381 |
Synth | 5.073 |
Natural Product Likeliness | 3.465 |
NR-PPAR-gamma | 0.956 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.028 |
Pgp-sub | 0 |
HIA | 0.006 |
CACO-2 | -4.832 |
MDCK | 0.0000226 |
BBB | 0.159 |
PPB | 0.654767 |
VDSS | 1.667 |
FU | 0.192584 |
CYP1A2-inh | 0.024 |
CYP1A2-sub | 0.419 |
CYP2c19-inh | 0.037 |
CYP2c19-sub | 0.854 |
CYP2c9-inh | 0.06 |
CYP2c9-sub | 0.082 |
CYP2d6-inh | 0.009 |
CYP2d6-sub | 0.6 |
CYP3a4-inh | 0.126 |
CYP3a4-sub | 0.451 |
CL | 19.624 |
T12 | 0.198 |
hERG | 0.022 |
Ames | 0.168 |
ROA | 0.384 |
SkinSen | 0.77 |
Carcinogencity | 0.709 |
EI | 0.133 |
Respiratory | 0.908 |
NR-Aromatase | 0.408 |
Antiviral | Yes |
Prediction | 0.714309 |